Sunitinib-induced thyrotoxicosis.
Piñar
D
D
Boix
E
E
Meana
J A
JA
Herrero
J
J
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002231:Carbimazole / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib; D013963:Thyroid Hormones / Q000097:blood; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000188:drug therapy
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D013963:Thyroid Hormones; D002231:Carbimazole; D011433:Propranolol; D000077210:Sunitinib; D011241:Prednisone